🔎 Trials Near Me

Gara Jalqabaatti › Glioma › Massachusetts › Boston

Qorannoo klinikaalii Glioma Boston, MA keessatti

Qorannoo 20 Glioma f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

MCT for the Harvard/UCSF ROBIN Center

Namoota walitti qabaa jira
  • Brigham and Women's Hospital, Boston
Umuriin hundi · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06000787

A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana-Farber Cancer Institute, Boston
12 Months – 21 Years · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT05099003

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Namoota walitti qabaa jiraSadarkaa 2
  • Massachusetts General Hospital, Boston
  • Beth Israel Deaconess Medical Center, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07326566

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute., Boston
Hanga umuriin 25 · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT04094610

Targeted Pediatric High-Grade Glioma Therapy

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05839379

Study of Olutasidenib and Temozolomide in HGG

Namoota walitti qabaa jiraSadarkaa 2
  • Susan Chi, Boston
Umuriin 12 hanga 39 · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Namoota walitti qabaa jiraSadarkaa 3
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Hag-2026 · NCT05303519

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
Umuriin 3 hanga 39 · Saalaa hunda · Haaromfame 24-Hag-2026 · NCT05096481

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site, Boston
Umuriin 18 hanga 130 · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05417594

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Namoota walitti qabaa jiraSadarkaa 2
  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Umuriin 8 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT05503797

CARv3-TEAM-E T Cells in Glioblastoma

Namoota walitti qabaa jiraSadarkaa 1
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2026 · NCT05660369

Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion

Namoota walitti qabaa jiraSadarkaa jalqabaa 1Hojjettoota fayyaa simatamoo
  • Dana-Farber Cancer Institute, Boston
Umuriin 1 hanga 21 · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT06333899

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Namoota walitti qabaa jiraSadarkaa 2
  • Dana-Farber Cancer Institute, Boston
12 Months – 39 Years · Saalaa hunda · Haaromfame 29-Cam-2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Namoota walitti qabaa jiraSadarkaa 1/2
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Elb-2026 · NCT06810544

A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
  • Dana-Farber Cancer Institute, Boston
Hanga umuriin 21 · Saalaa hunda · Haaromfame 18-Bit-2026 · NCT04655404

rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG

Namoota walitti qabaa jiraSadarkaa 1
  • Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston
12 Months – 18 Years · Saalaa hunda · Haaromfame 17-Bit-2026 · NCT04943848

CUE-102 in Recurrent Glioblastoma

Namoota walitti qabaa jiraSadarkaa 1
  • Brigham and Women's Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Bit-2026 · NCT06917885

NeuroPathways Intervention for Brain Tumor Patients

Namoota walitti qabaa jira
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Mud-2025 · NCT05976490

ASCENT Intervention for Brain Tumor Patients

Namoota walitti qabaa jira
  • Massachusetts General Hospital Cancer Center, Boston
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Ado-2025 · NCT06099743

The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Massachusetts General Hospital, Boston
Umuriin 18 hanga 90 · Saalaa hunda · Haaromfame 22-Gur-2024 · NCT06118723

Qorannoo Glioma magaalota biroo keessatti

Qorannoo biroo Boston keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.